These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29066891)

  • 21. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
    Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
    Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
    Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity.
    Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF
    J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
    Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
    Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan Oligosaccharide Modified Bovine Serum Albumin Nanoparticles for Improving Oral Bioavailability of Naringenin.
    Fang R; Liao Y; Qiu H; Liu Y; Lin S; Chen H
    Curr Drug Deliv; 2024; 21(8):1142-1150. PubMed ID: 37464826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats.
    Zhang G; Zhang J
    Drug Des Devel Ther; 2018; 12():2509-2518. PubMed ID: 30147298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
    Bairwa K; Jachak SM
    J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery.
    Li Y; Zhao X; Zu Y; Zhang Y; Ge Y; Zhong C; Wu W
    Int J Pharm; 2015; 486(1-2):207-16. PubMed ID: 25841566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
    Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
    Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
    Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology.
    Guo F; Guo D; Zhang W; Yan Q; Yang Y; Hong W; Yang G
    Eur J Pharm Sci; 2017 Mar; 99():328-336. PubMed ID: 28062259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.